Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy

Rheumatology International

Volumn 31, Issue 1, 2011, Pages 65-69

  Ezzat, Wafaa M ^a   Raslan, Hala M ^a   Aly, Azza A ^a   Emara, Nahed A ^a   El Menyawi, Manal M ^b   Edrees, Amr ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Anti cyclic citrullinated peptide antibodies; Hepatitis C related polyarthropathy; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C RELATED POLYARTHROPATHY; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78751591709     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1225-8     Document Type: Article

References (25)

1. P Cacoub T Poynard P Ghillani F Charlotte M Olivi JC Piette P Opolon 1999 Extra-hepatic manifestations of chronic hepatitis C. MULTIVIRC Group (Multidepartment Virus C) Arthritis Rheum 42 2204 2212 1:STN:280: DyaK1Mvlt1ehtA%3D%3D 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0. CO;2-D 10524695 (Pubitemid 30263607)
2. X Mariette 1998 The hepatitis C virus and systemic diseases Rev Rheum 65 737 740 1:STN:280:DyaK1M7itFOqtw%3D%3D
3. J Rivera A Garcia-Monforte A Pineda J Millan Nunez-Cortes 1999 Arthritis in patients with chronic hepatitis C virus infection J Rheumatol 26 420 424 1:STN:280:DyaK1M7jslaltg%3D%3D 9972979
4. D Buskila A Shnaider L Neumann D Zilberman N Hilzenrat 1998 Musculoskeletal manifestations and autoantibodies profile in 90 hepatitis C virus infected Israeli patients Semin Arthritis Rheum 28 107 113 1:STN:280:DyaK1M%2FitFajug%3D%3D 10.1016/S0049-0172(98)80043-7 9806371 (Pubitemid 28480895)
5. E Zuckerman D Keren M Rozenbaum 2000 Hepatitis C virus related arthritis: characteristics and response to therapy with interferon alpha Clin Exp Rheumatol 18 579 584 1:STN:280:DC%2BD3crhsVKktA%3D%3D 11072597
6. N Bizzaro G Mazzanti E Tonutti D Villalta R Tozzoli 2001 Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis Clin Chem 47 1089 1093 1:CAS:528:DC%2BD3MXktFels78%3D 11375296
7. I Olivieri C Palazzi A Padula 2003 Hepatitis C virus and arthritis Rheum Dis Clin North Am 29 111 122 10.1016/S0889-857X(02)00097-2 12635503 (Pubitemid 36298106)
8. K Aho T Palusuo P Kurki 1994 Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications Semin Arthritis Rheum 23 379 387 1:STN:280:DyaK2M%2FisF2rsw%3D%3D 10.1016/0049-0172(94)90088-4 7524151
9. A Kessel I Rosner E Zuckerman TD Golan E Toubi 2000 Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection J Rheumatol 27 610 612 1:STN:280:DC%2BD3c3gsFKgug%3D%3D 10743797
10. S Bas TV Perneger M Seitz JM Tiercy P Roux-Lombard P Guerne 2002 Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies and IgM rheumatoid factors Rheumatology (Oxford) 41 809 814 1:CAS:528:DC%2BD38Xmt1Ohs7k%3D 10.1093/rheumatology/41.7.809
11. O Vittecoq B Incaurgarat F Jouen-Beades J Legoedec O Ltourneur D Rolland 2004 Auto antibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis Clin Exp Immunol 135 173 180 1:CAS:528:DC%2BD2cXnslGjtA%3D%3D 10.1111/j.1365-2249.2004.02341.x 14678280 (Pubitemid 38067943)
12. FC Arnett SM Edworthy DA Bloch D McShane JJ Fries N Cooper 1998 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302
13. P Cacoub C Renou E Rosenthal P Cohen I Loury V Loustaud-Ratti AM Yamamoto AC Camproux P Hausfater L Musset P Veyssier G Raguin JC Piette 2000 Extra hepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC (Groupe d'Étude et de Recherche en Médecine Interne et Maladies Infectieuses sur le Virus de l'Hépatite C) Medicine (Baltimore) 79 47 56 1:STN:280:DC%2BD3c7jsFejtw%3D%3D 10.1097/00005792-200001000-00005 (Pubitemid 30077736)
14. T Palosuo R Tilvis T Strandberg K Aho 2003 Filaggrin related antibodies among the aged Ann Rheum Dis 62 261 263 1:STN:280:DC%2BD3s%2Fot1KjsA%3D%3D 10.1136/ard.62.3.261 12594116 (Pubitemid 36238094)
15. D Sène P Ghillani-Dalbin N Limal V Thibault T van Boekel J Piette P Cacoub 2006 Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren's syndrome Ann Rheum Dis 65 394 397 10.1136/ard.2005.038042 16474032 (Pubitemid 43268232)
16. M Bombardieri C Alessandri G Labbadia C Lannuccelli F Carlucci V Riccieri V Paoletti G Valesini 2004 Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement Arthritis Res Ther 6 R137 R141 1:CAS:528:DC%2BD2cXjvFGju7k%3D 10.1186/ar1041 15059277
17. GC Pinheiro MA Scheinberg M Aparecida da Silva S Maciel 2003 Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis Ann Intern Med 139 234 235 12899598
18. WJ Van Venrooij JM Hazes H Visser 2002 Anti-citrullinated protein/ peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis Neth J Med 2002 60 383 388
19. MH Wener K Hutchinson C Morishima DR Gretch 2004 Absence of Antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia Arthritis Rheum 50 2305 2308 1:CAS:528: DC%2BD2cXmsVantr0%3D 10.1002/art.20355 15248231 (Pubitemid 38924410)
20. S Rantapää-Dahlqvist B de Jong E Berglin 2003 Antibodies against citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum 48 2741 2749 10.1002/art.11223 14558078 (Pubitemid 37280601)
21. MM Nielen D van Schaardenburg H Reesing 2004 Specific auto antibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors Arthritis Rheum 50 380 386 10.1002/art.20018 14872479 (Pubitemid 38198821)
22. F Van Gaalen S Linn-Rasker W van Venrooij 2004 Autoantibidies to cyclic citrullinated peptides (CCP) predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study Arthritis Rheum 50 709 715 10.1002/art.20044 15022309 (Pubitemid 38326168)
23. ER Vossenaar WJ van Venrooij 2004 Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis Arthritis Res 6 3 107 111 1:CAS:528:DC%2BD2cXot1WlsrY%3D 10.1186/ar1184
24. MR Lovy G Starkebaum S Uberoi 1996 Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis J Rheumatol 23 979 983 1:STN:280:DyaK28znsFygtQ%3D%3D 8782126
25. MY Mok WL Ng MF Yuen RW Wong CS Lau 2000 Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis Clin Exp Rheumatol 18 363 368 1:STN:280:DC%2BD3M%2FitVGjsA%3D%3D 10895374